FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Clinical trials for FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS explained in plain language.

Never miss a new study

Get alerted when new FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear

Sign up with your email to follow new studies for FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New drug combo shows promise for kids with rare immune disease

Disease control Completed

This study tested a drug called alemtuzumab (Campath) as a first treatment for children with hemophagocytic lymphohistiocytosis (HLH), a rare and life-threatening immune disorder. The goal was to see if it could help children survive until they could receive a stem cell transplan…

Matched conditions: FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Phase: PHASE1, PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC

FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Get alerted when new FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear

New drug combo shows promise for kids with rare immune disease